Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry
Results 81 - 100 out of 500 displayed.
« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »
Reset ↻

Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of Inhaled KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors of the Lung

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Krystal Biotech, Inc.

Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Plus Therapeutics, Inc.

BioXcel Therapeutics Announces Plan for Evaluating BXCL501 in the At-Home Setting to Expand Its Market Potential

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: BioXcel Therapeutics, Inc.

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Centessa Pharmaceuticals Limited

XORTX Announces Publication of Key Research in ADPKD

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: XORTX Therapeutics Inc

BioCryst to Report First Quarter 2024 Financial Results on May 6

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: BioCryst Pharmaceuticals, Inc.

Kraig Biocraft Laboratories Successfully Completes Recombinant Cocoon Production From Spring Trials

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Kraig Biocraft Laboratories, Inc.

Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Kura Oncology, Inc.

Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Lexeo Therapeutics, Inc.

Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Cognition Therapeutics, Inc.

Stereotaxis to Report First Quarter 2024 Financial Results on May 13, 2024

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Stereotaxis, Inc.

Sagimet Biosciences to Host Virtual Investor and Analyst Day on Inhibiting Fatty Acid Synthase (FASN) to Reduce Liver Fat, Inflammation and Fibrosis in MASH on May 3, 2024

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Sagimet Biosciences

Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Enlivex Therapeutics Ltd.

Ocuphire Pharma Announces APX3330 Presentation at ARVO 2024 Annual Meeting

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Ocuphire Pharma, Inc.

Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Panbela Therapeutics, Inc.

SS Innovations International Announces Q1 2024 Company Updates

Read more ››

By: GlobeNewswire - 22 Apr 2024

Excision BioTherapeutics Announces Oral Presentation of Preclinical HSV-1 Keratitis Data at CRISPRMED24 Conference on April 24, 2024

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Excision BioTherapeutics, Inc.

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Corcept Therapeutics Incorporated

INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds Through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: INmune Bio Inc.

Celularity Inc. to Host Investor and Analyst Research & Development Day

Read more ››

By: GlobeNewswire - 22 Apr 2024

Related companies: Celularity Inc.

« 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 »

to the top ↑